← Back to catalogue

Mammotome Revolve Dual Vacuum Assisted Biopsy (VAB) System

FDA 510(k)FDA UDIEUDAMED

Class II (US FDA 510(k))

510(k) K202012Ref MFOOT1

by Devicor Medical Products, Inc.

Identity

Trade Name
Mammotome Revolve™ Dual Vacuum-Assisted Biopsy System EUDAMED
Mammotome revolve FDA UDI
Generic Name
Mammographic stereotactic biopsy system FDA UDI
Device Name
Footswitch EUDAMEDFDA UDI
Model / Reference
MFOOT1 EUDAMEDFDA UDI
Description
Footswitch FDA UDI

Identifiers

Primary DI / UDI-DI
00841911100669 EUDAMEDFDA UDI
Basic UDI-DI
08419111AD02G000003322V4 EUDAMED
510(k) Number
K202012 FDA 510(k)
K152989 FDA UDI
FDA Product Code
KNW FDA 510(k)FDA UDI
EMDN Code
A019012 BREAST NODULES AND OTHER STRUCTURES LOCALISATION NEEDLES AND SYSTEMS EUDAMED
GMDN Term
Mammographic stereotactic biopsy system FDA UDI

Classification

Device Class
Class I EUDAMED
Class II FDA 510(k)FDA UDI
Legislation / Framework
21 CFR Part 876.1075 FDA 510(k)
Regulation Number
876.1075 FDA 510(k)FDA UDI
Market of Registration
Netherlands EUDAMED
Advisory Committee
Gastroenterology, Urology FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

EUDAMEDFDA UDI

Single Use

No

FDA UDI

Implantable

No

EUDAMEDFDA UDI

Reusable

No

EUDAMED

Contains Latex

No

EUDAMEDFDA UDI

Reprocessed

No

EUDAMED

CMR Substance

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Endocrine Disruptor

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

Yes

FDA UDI

The Mammotome Revolve Dual Vacuum-Assisted Biopsy System is a vacuum-assisted breast biopsy device designed for tissue acquisition in breast procedures. It employs dual vacuum technology to excise targeted tissue samples, enabling precise and controlled removal of lesions or suspicious areas. This system is classified under vacuum-assisted biopsy devices and is intended for stereotactic-guided, ultrasound-guided, or open biopsy procedures in breast tissue. Its automated specimen management enhances sample integrity and organization for pathology review.

The device is supplied as a reusable system with disposable components, including biopsy needles and specimen collection chambers. It is intended for use in clinical settings such as radiology suites, surgical centers, and breast clinics, where MRI safety is not a primary concern. The system includes interchangeable biopsy needles in various gauges and lengths, tailored to different lesion sizes and procedural requirements. Sterility is maintained through single-use disposable components, and proper storage involves keeping the reusable components in a clean, dry environment as per manufacturer guidelines. Authorized for use under FDA 510(k) clearance and MDR compliance, it adheres to regulatory standards for medical devices.

Frequently asked questions

What types of biopsy procedures can the Mammotome Revolve Dual Vacuum Assisted Biopsy System be used for in breast tissue?

The Mammotome Revolve Dual Vacuum Assisted Biopsy System is designed for stereotactic-guided, ultrasound-guided, or open biopsy procedures in breast tissue. Its dual vacuum technology allows precise excision of targeted lesions or suspicious areas, making it versatile for different clinical approaches where MRI safety is not a concern.

Are the biopsy needles included with the Mammotome Revolve system reusable or disposable, and what sizes are available?

The Mammotome Revolve system includes disposable biopsy needles in interchangeable gauges and lengths, tailored to accommodate various lesion sizes and procedural needs. The reusable components of the system (e.g., the core device) require proper cleaning and storage, while the single-use needles ensure sterility for each procedure.

How is sterility maintained when using the Mammotome Revolve Dual Vacuum Assisted Biopsy System, and what storage guidelines apply?

Sterility is maintained through the use of single-use disposable components, including biopsy needles and specimen collection chambers. The reusable parts of the system must be stored in a clean, dry environment as directed by the manufacturer to prevent contamination between uses.

In what clinical settings is the Mammotome Revolve system intended for use, and why?

The system is intended for use in radiology suites, surgical centers, and breast clinics, where MRI safety is not a primary concern. Its design supports precise tissue acquisition for pathology review, making it suitable for environments where breast biopsies are performed under stereotactic, ultrasound, or open guidance.

What regulatory pathways does the Mammotome Revolve Dual Vacuum Assisted Biopsy System follow, and what does that mean for its use?

The system is authorized under FDA 510(k) clearance and MDR compliance, meaning it has undergone regulatory review to demonstrate substantial equivalence to prior-generation devices. This clearance allows clinicians to use it with confidence that it meets established safety and performance standards for vacuum-assisted breast biopsy procedures.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: Mammotome Revolve™ Vacuum-Assisted Breast Biopsy System| Mammotome, PDF Mammotome Revolve™ dual vacuum-assisted breast biopsy system for, Mammotome Revolve™ Biopsy System | Mammotome

Authorization Coverage (2 countries)

Regulatory Authorizations

European Union Active

MDR

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (3)

  • FDA 510(k) K202012 24 fields · synced Oct 6, 2026
  • FDA UDI 1d11e92c-aa4e-4fdc-ba37-b132186d38ad 36 fields · synced May 30, 2026
  • EUDAMED 1c4c6e44-a00c-4090-b35a-252c485ff0a0 61 fields · synced Jul 15, 2026